Clinicopathological, Genomic Characteristics and Prognostic Analysis in 18 Cases of SMARCA4-deficient or SMARCA4-mutated Pulmonary Tumors.
Background and objective The diagnosis of SMARCA4-altered pulmonary tumors primarily relies on the detection of protein loss by immunohistochemistry (IHC). However, the concordance between IHC and genetic testing results, as well as the clinical and biological differences caused by various mutation...
| Publicado en: | Chinese Journal of Lung Cancer Vol. 29; no. 3; pp. 180 - 190 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | diagnostic images pictorial research tables/charts Journal Article |
| Publicado: |
Chinese Journal of Lung Cancer
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |